A first-of-its-kind medical device to treat childhood ADHD has been approved by the FDA.
The Monarch External Trigeminal Nerve Stimulation System was given the okay on Friday.
It’s designated for children ages 7 to 12 who are not currently on medication for the disorder.
And it’s designed to be used while the child sleeps.
A small adhesive patch is placed on a child’s forehead and a pocket-sized device delivers a low-level electrical pulse to the parts of the brain responsible for ADHD symptoms.
The device has also been investigated as a possible treatment for traumatic brain injury in veterans.